{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:19:05Z","timestamp":1780503545648,"version":"3.54.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T00:00:00Z","timestamp":1644624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials and Biosystems"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.bbiosy.2022.100042","type":"journal-article","created":{"date-parts":[[2022,2,13]],"date-time":"2022-02-13T09:27:45Z","timestamp":1644744465000},"page":"100042","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Engineered extracellular vesicles antagonize SARS-CoV-2 infection by inhibiting mTOR signaling"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1657-7432","authenticated-orcid":false,"given":"A.G.","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ciullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Peck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Arumugaswami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Marb\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbiosy.2022.100042_bib0001","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19 - final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbiosy.2022.100042_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.635371","article-title":"Lack of effectiveness of repurposed drugs for COVID-19 treatment","volume":"12","author":"Martinez","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.bbiosy.2022.100042_bib0003","article-title":"Drug-drug interactions could imperil COVID-19 treatment","author":"Pinkowski","year":"2020","journal-title":"Medscape"},{"key":"10.1016\/j.bbiosy.2022.100042_bib0004","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.afos.2018.11.083","article-title":"The advantages and limitations of mesenchymal stem cells in clinical application for treating human diseases","volume":"4","author":"Lee","year":"2018","journal-title":"Osteoporos Sarcopenia"},{"key":"10.1016\/j.bbiosy.2022.100042_bib0005","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/prca.201400114","article-title":"Exosomes in bodily fluids are a highly stable resource of disease biomarkers","volume":"9","author":"Boukouris","year":"2015","journal-title":"Proteom Clin Appl"},{"key":"10.1016\/j.bbiosy.2022.100042_bib0006","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1146\/annurev-physiol-021115-104929","article-title":"Exosomes: fundamental biology and roles in cardiovascular physiology","volume":"78","author":"Ibrahim","year":"2016","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.bbiosy.2022.100042_bib0007","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41551-019-0448-6","article-title":"Augmenting canonical Wnt signalling in therapeutically inert cells converts them into therapeutically potent exosome factories","volume":"3","author":"Ibrahim","year":"2019","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.bbiosy.2022.100042_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.733158","article-title":"Engineered fibroblast extracellular vesicles attenuate pulmonary inflammation and fibrosis in bleomycin-induced lung injury","volume":"9","author":"Ibrahim","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.bbiosy.2022.100042_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108959","article-title":"Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2","volume":"35","author":"Dittmar","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.bbiosy.2022.100042_bib0014","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1128\/AAC.03659-14","article-title":"Antiviral potential of ERK\/MAPK and PI3K\/AKT\/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis","volume":"59","author":"Kindrachuk","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbiosy.2022.100042_bib0015","article-title":"mTOR inhibition and p53 activation, microRNAs: the possible therapy against pandemic COVID-19","volume":"20","author":"Ramaiah","year":"2020","journal-title":"Gene Rep"},{"key":"10.1016\/j.bbiosy.2022.100042_bib0016","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1038\/s41467-021-22166-4","article-title":"SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition","volume":"12","author":"Mullen","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.bbiosy.2022.100042_bib0017","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1080\/22221751.2020.1799723","article-title":"Dysregulation in Akt\/mTOR\/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells","volume":"9","author":"Appelberg","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.bbiosy.2022.100042_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108940","article-title":"Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication","volume":"35","author":"Garcia","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.bbiosy.2022.100042_bib0025","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fmicb.2012.00092","article-title":"IRES-dependent translational control during virus-induced endoplasmic reticulum stress and apoptosis","volume":"3","author":"Hanson","year":"2012","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bbiosy.2022.100042_bib0026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006635","article-title":"Influenza virus differentially activates mTORC1 and mTORC2 signaling to maximize late stage replication","volume":"13","author":"Kuss-Duerkop","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.bbiosy.2022.100042_bib0027","article-title":"mTOR inhibition in COVID-19: a commentary and review of efficacy in RNA viruses","author":"Karam","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.bbiosy.2022.100042_bib0028","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1093\/eurheartj\/ehab419","article-title":"Extracellular vesicles from immortalized cardiosphere-derived cells attenuate arrhythmogenic cardiomyopathy in desmoglein-2 mutant mice","volume":"42","author":"Lin","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.bbiosy.2022.100042_bib0029","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bbiosy.2022.100042_bib0030","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinform"}],"container-title":["Biomaterials and Biosystems"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666534422000046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666534422000046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T01:16:46Z","timestamp":1762996606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666534422000046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":20,"alternative-id":["S2666534422000046"],"URL":"https:\/\/doi.org\/10.1016\/j.bbiosy.2022.100042","relation":{},"ISSN":["2666-5344"],"issn-type":[{"value":"2666-5344","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineered extracellular vesicles antagonize SARS-CoV-2 infection by inhibiting mTOR signaling","name":"articletitle","label":"Article Title"},{"value":"Biomaterials and Biosystems","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbiosy.2022.100042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100042"}}